Global Substance Abuse Treatment Market, By Type, By Treatment Type, By Age Group, By Treatment Setting, By Geography

Description

Global substance abuse treatment market was valued US$ 11.8 Bn in 2023 and is expected to reach US$ 22.8 Bn by 2031 exhibiting a compound annual growth rate (CAGR) of 8.6% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 11.8 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 - 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	8.60%	2030/2031 Value Projection:	US$ 22.8 Bn

Figure 1. Global Substance Abuse Treatment Market Share (%), By Region, 2023

Global Substance Abuse Treatment Market - IMG1

Substance abuse treatment refers to programs and activities that are aimed at managing substance dependence and support long-term sobriety and recovery. Substance abuse disorder which is also known as addiction, involves the compulsive or uncontrollable use of harmful and addictive substances despite their negative impact. Common substances of abuse include alcohol, opioids, cannabis, cocaine, and methamphetamines. Some key signs of substance abuse disorder include the inability to reduce intake, experiencing cravings, and having withdrawal symptoms when not using. Those suffering from addiction often experience impaired control, social problems, risky use, and sometimes even physical dependence. Substance abuse treatment aims to address the biological, psychological, social, and behavioral aspects of addiction through therapeutic interventions, counseling, medication, and community support programs. The rise in substance abuse rates globally is fueling demand for effective treatment options.

Market Dynamics:

Global substance abuse treatment market is driven by the rising prevalence of substance abuse disorders, increasing awareness regarding treatment availability, favorable regulations and reimbursement policies, and the launch of novel medication-assisted treatment products. However, the market growth can be restrained by social stigmas that are associated with addiction, lack of access to treatment facilities in low-income regions, and non-compliance issues with treatment protocols. The development of digital therapeutic solutions, integrated care models, targeted therapies for specific addictions, and expansion to emerging markets present key opportunities for the market players. Geographically, North America dominates the market due to advanced healthcare infrastructure and awareness. However, the Asia Pacific region is expected to offer lucrative growth prospects during the forecast period.

Key Features of the Study:

This report provides an in-depth analysis of the global substance abuse treatment market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global substance abuse treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Indivior PLC, Pfizer, Inc., Johnson & Johnson Inc., Alkermes., Mallinckrodt Pharmaceuticals, Teva Pharmaceuticals, Inc., Par Pharmaceutical, Inc., USWM, LLC, Valeant Pharmaceuticals, Greenyard Pharmaceutical Ltd. Cipla Health Limited. Perrigo, Haleon Group of Companies, Ventus Medical, Glenmark and other prominent players.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global substance abuse treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global substance abuse treatment market.

Detailed Segmentation:

Global Substance Abuse Treatment Market, By Type
- Alcohol
- Opioids (e.g., heroin, prescription painkillers)
- Tobacco/nicotine
- Cocaine
- Marijuana
- Methamphetamines
- Other illicit drugs (Benzodiazepines, etc.)
Global Substance Abuse Treatment Market, By Treatment Type
- Opioid
- Methadone
- Buprenorphine
- Extended-release naltrexone
- Lofexidine
- Nicotine
- Nicotine replacement therapies (available as a patch, inhaler, or gum)
- Bupropion
- Varenicline
- Alcohol
- Naltrexone
- Disulfiram
- Acamprosate
- Tobacco
- Clonidine
- Nortriptyline
- Others (Topiramate, Modafinil, etc.)
Global Substance Abuse Treatment Market, By Age Group
- Adolescents
- Adults
- Geriatric
Global Substance Abuse Treatment Market, By Treatment Setting
- Outpatient Treatment
- Outpatient Clinics
- Private Practices
- Inpatient Treatment
- Rehabilitation Centers
- Hospitals
- Residential Treatment Facilities
- Detoxification Centers
Global Substance Abuse Treatment Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Top Companies in the Global Substance Abuse Treatment Market:
- Indivior PLC
- Pfizer, Inc.
- Johnson & Johnson Inc.
- Mallinckrodt Pharmaceuticals
- Teva Pharmaceuticals, Inc.
- Par Pharmaceutical, Inc.
- USWM, LLC
- Valeant Pharmaceuticals
- Greenyard Pharmaceutical Ltd
- Cipla Health Limited
- Perrigo
- Haleon Group of Companies
- Ventus Medical
- Glenmark
- Other Prominent Players

Product Code: CMI6671

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Type
- Market Snippet, By Treatment Type
- Market Snippet, By Age Group
- Market Snippet, By Treatment Setting
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers:
Increasing consumption of drugs and alcohol
Growing support from government and NGOs
- Restraints
Social stigma associated with substance dependence
Lack of adequate rehabilitation facilities
- Opportunities
Untapped markets in developing countries
Company Market Share Analysis
Key Highlights
Market Trends
PEST Analysis
PORTER's Analysis
Recent Product Approvals/Launches
Mergers, Acquisitions, and Collaborations

4. Global Substance Abuse Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Substance Abuse Treatment Market, By Type, 2019-2031, (US$ Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Alcohol
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Opioids (e.g., heroin, prescription painkillers)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Tobacco/nicotine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Cocaine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Marijuana
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Methamphetamines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Other illicit drugs (Benzodiazepines, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

6. Global Substance Abuse Treatment Market, By Treatment Type, 2019-2031, (US$ Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Opioid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Methadone
Buprenorphine
Extended-release naltrexone
Lofexidine
Nicotine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Nicotine replacement therapies (available as a patch, inhaler, or gum)
Bupropion
Varenicline
Alcohol
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Naltrexone
Disulfiram
Acamprosate
Tobacco
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Clonidine
Nortriptyline
Others (Topiramate, Modafinil, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

7. Global Substance Abuse Treatment Market, By Age Group, 2019-2031, (US$ Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Adolescents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

8. Global Substance Abuse Treatment Market, By Treatment Setting, 2019-2031, (US$ Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Outpatient Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Outpatient Clinics
Private Practices
Inpatient Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Rehabilitation Centers
Hospitals
Residential Treatment Facilities
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Detoxification Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

9. Global Substance Abuse Treatment Market, By Region, 2019-2031, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019 - 2031
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019-2031,(US$ Bn)
North Africa
Central Africa
South Africa

10. Competitive Landscape

Company Profile
- Indivior PLC
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Pfizer, Inc.
- Johnson & Johnson Inc.
- Mallinckrodt Pharmaceuticals
- Teva Pharmaceuticals, Inc.
- Par Pharmaceutical, Inc.
- USWM, LLC
- Valeant Pharmaceuticals
- Greenyard Pharmaceutical Ltd
- Cipla Health Limited
- Perrigo
- Haleon Group of Companies
- Ventus Medical
- Glenmark
- Other Prominent Players
Analyst Views

11. Section

References
Research Methodology
About us